1. Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children. (January 2023) Authors: Puga-Gómez, Rinaldo; Ricardo-Delgado, Yariset; Rojas-Iriarte, Chaumey; Céspedes-Henriquez, Leyanis; Piedra-Bello, Misleidys; Vega-Mendoza, Dania; Pérez, Noelvia Pestana; Paredes-Moreno, Beatriz; Rodríguez-González, Meiby; Valenzuela-Silva, Carmen; Sánchez-Ramírez, Belinda; Rodríguez-Noda, Laura; ... Journal: International journal of infectious diseases Issue: Volume 126(2023) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗